Axa S.A. Obs Eva Sa Transaction History

Axa S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$2.48 - $8.1 $1.21 Million - $3.95 Million	-487,103 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$8.22 - $11.2 $108,586 - $147,952	-13,210 Reduced 2.64%	487,103 $4.06 Million
Q2 2019 Aug 13, 2019	BUY	$10.05 - $14.25 $365,377 - $518,073	36,356 Added 7.84%	500,313 $5.66 Million
Q1 2019 May 14, 2019	BUY	$11.82 - $14.48 $1.14 Million - $1.4 Million	96,457 Added 26.25%	463,957 $5.93 Million
Q2 2018 Aug 13, 2018	BUY	$10.0 - $17.87 $3.68 Million - $6.57 Million	367,500 New	367,500 $5.56 Million

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.